XORTX Therapeutics Inc Financial Flexibility Index
XORTX Therapeutics Inc financial flexibility index. XORTX Therapeutics Inc (XRTX) has a Financial Flexibility Index of -0.75x as of September 2025. Free cash flow of CA$-624.13K (operating CF CA$-629.62K minus capex CA$5.49K) represents -1% of total liabilities (CA$837.41K). See XRTX cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of XORTX Therapeutics Inc (2018–2024)
Financial flexibility index of XORTX Therapeutics Inc from 2018 to 2024. Historical Financial Flexibility Index trend for XORTX Therapeutics Inc across 7 annual periods. Check XRTX cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
XORTX Therapeutics Inc Financial Flexibility Index by Year (2018–2024)
XORTX Therapeutics Inc financial flexibility index by year from 2018 to 2024. Year-by-year free cash flow to debt coverage for XORTX Therapeutics Inc. For the full cash flow conversion analysis, see cash efficiency ratio of XORTX Therapeutics Inc.
| Year | Flexibility Index | Free Cash Flow (CAD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.80x | CA$-3.64 Million | CA$-3.68 Million | CA$757.99K | ▲ +39.3% |
| 2023 | -7.91x | CA$-6.54 Million | CA$-6.58 Million | CA$825.94K | ▼ -255.8% |
| 2022 | -2.22x | CA$-11.94 Million | CA$-11.97 Million | CA$5.37 Million | ▼ -95.2% |
| 2021 | -1.14x | CA$-6.04 Million | CA$-6.06 Million | CA$5.30 Million | ▼ -67.7% |
| 2020 | -0.68x | CA$-702.62K | CA$-728.40K | CA$1.03 Million | ▼ -294.5% |
| 2019 | -0.17x | CA$-223.80K | CA$-249.58K | CA$1.30 Million | ▲ +89.3% |
| 2018 | -1.60x | CA$-1.51 Million | CA$-1.56 Million | CA$943.70K | — |